Dr. Madhu Gargesha of BioInVision presented a paper titled “MSC pre-treatments lead to better cell survival in mouse models of liver disease: A CryoViz Study” at the American Association of Immunologists (AAI) 2016 Conference in Seattle, Washington, USA, May 13-16 2016. The presentation was very well received and generated a lot of interest in the MERLIN project. You can find more details about the Conference here.
- RT @MesenchymalCell: MSCs: Potential Application for the Treatment of Hepatic Cirrhosis t.co/lB1Pi8BQuC t.co/GwJ5to4Yil Time ago 18 Hours via Twitter for iPhone
- RT @nephstrom: The long and fascinating trip of stem cell research has started!! #unistemday2018 #stemcellresearch @Unistem2018 Best wishes… Time ago 4 Days via Twitter Web Client
- RT @Unistem2018: 270 high Schools from 10 European Countries together #unistem2018 Time ago 4 Days via Twitter Web Client
Follow @fp7merlin on twitter.
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602363. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.